Literature DB >> 19352389

Focal therapy for prostate cancer.

Peter T Scardino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19352389     DOI： 10.1038/nrurol.2009.52

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  4 in total

1.  The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.

Authors:  Amita Shukla-Dave; Hedvig Hricak; Michael W Kattan; Darko Pucar; Kentaro Kuroiwa; Hui-Ni Chen; Jessica Spector; Jason A Koutcher; Kristen L Zakian; Peter T Scardino
Journal:  BJU Int       Date:  2007-01-12       Impact factor: 5.588

2.  Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.

Authors:  Ryan K Berglund; Timothy A Masterson; Kinjal C Vora; Scott E Eggener; James A Eastham; Bertrand D Guillonneau
Journal:  J Urol       Date:  2008-09-17       Impact factor: 7.450

3.  Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.

Authors:  Winston E Barzell; Myron R Melamed
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

4.  Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Authors:  Susan R Harlan; Matthew R Cooperberg; Eric P Elkin; Deborah P Lubeck; Maxwell V Meng; Shilpa S Mehta; Peter R Carroll
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450
  4 in total
  1 in total

1.  Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution.

Authors:  Elliot Anderson; Lloyd M L Smyth; Richard O'Sullivan; Andrew Ryan; Nathan Lawrentschuk; Jeremy Grummet; Andrew W See
Journal:  Transl Androl Urol       Date:  2021-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.